Goldman Sachs’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,706,600
Closed -$116M 5701
2022
Q3
$116M Buy
1,706,600
+1,033,433
+154% +$70.4M 0.03% 537
2022
Q2
$21.5M Sell
673,167
-1,160,553
-63% -$37.1M 0.01% 1568
2022
Q1
$63.5M Buy
1,833,720
+595,983
+48% +$20.6M 0.01% 927
2021
Q4
$36.2M Buy
1,237,737
+461,580
+59% +$13.5M 0.01% 1346
2021
Q3
$19.8M Buy
776,157
+110,167
+17% +$2.81M ﹤0.01% 1738
2021
Q2
$23.3M Buy
665,990
+195,041
+41% +$6.83M 0.01% 1624
2021
Q1
$19.2M Sell
470,949
-428,699
-48% -$17.5M ﹤0.01% 1707
2020
Q4
$39M Buy
899,648
+329,330
+58% +$14.3M 0.01% 1122
2020
Q3
$31.4M Sell
570,318
-43,336
-7% -$2.39M 0.01% 1182
2020
Q2
$38.7M Sell
613,654
-84,603
-12% -$5.34M 0.01% 1040
2020
Q1
$35.7M Buy
698,257
+148,545
+27% +$7.59M 0.01% 984
2019
Q4
$43.7M Buy
549,712
+131,126
+31% +$10.4M 0.01% 1108
2019
Q3
$20.3M Sell
418,586
-139,226
-25% -$6.76M 0.01% 1512
2019
Q2
$29.3M Buy
557,812
+42,536
+8% +$2.24M 0.01% 1352
2019
Q1
$27.3M Buy
515,276
+86,374
+20% +$4.57M 0.01% 1406
2018
Q4
$17.6M Buy
428,902
+4,224
+1% +$173K 0.01% 1597
2018
Q3
$16.1M Sell
424,678
-547
-0.1% -$20.8K ﹤0.01% 1772
2018
Q2
$19.2M Buy
425,225
+22,153
+5% +$1M 0.01% 1638
2018
Q1
$19.5M Buy
403,072
+129,737
+47% +$6.27M 0.01% 1592
2017
Q4
$10.8M Sell
273,335
-2,282
-0.8% -$89.8K ﹤0.01% 1873
2017
Q3
$8.56M Sell
275,617
-41,954
-13% -$1.3M ﹤0.01% 2060
2017
Q2
$8.69M Buy
317,571
+215,690
+212% +$5.9M ﹤0.01% 1998
2017
Q1
$3.75M Buy
101,881
+62,231
+157% +$2.29M ﹤0.01% 2360
2016
Q4
$573K Buy
+39,650
New +$573K ﹤0.01% 3370
2016
Q3
Sell
-68,529
Closed -$1.14M 4671
2016
Q2
$1.14M Sell
68,529
-60,330
-47% -$1M ﹤0.01% 2881
2016
Q1
$2.04M Buy
128,859
+104,139
+421% +$1.65M ﹤0.01% 2503
2015
Q4
$799K Buy
24,720
+18,721
+312% +$605K ﹤0.01% 3006
2015
Q3
$253K Buy
+5,999
New +$253K ﹤0.01% 3705